Ranbaxy to market Desvenlafaxine in the US

Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has entered into an in-licensing...

March 6, 2013 | Wednesday | News
India to review its pharma FDI policies

New Delhi: The Indian government will be reviewing the foreign direct investment (FDI) policies for the pharmaceutical i...

July 22, 2013 | Monday | Regulatory
DCGI nod for Zydus Cadila diabetic dyslipidemeia drug

Singapore: Days after the Drug Controller General of India (DCGI) approved Cadila Healthcare's new chemical entity, Lipa...

June 10, 2013 | Monday | News
Gilead, Teva to settle patent case of HIV drug

Singapore: Biopharmaceutical companies Gilead Sciences and Teva Pharmaceuticals have decided to settle the ongoing paten...

February 21, 2013 | Thursday | News
Police: Sexual favours spurred GSK's $1.5 bn China sales

Singapore: A day after making the allegations against GlaxoSmithKline's senior executives public, China's Public Securit...

July 16, 2013 | Tuesday | News
Shasun to focus on global regulatory markets

Singapore: Shasun pharmaceuticals an Indian pharmaceutical company, aims to focus on formulations manufacturing and mark...

June 2, 2014 | Monday | News
IOF, Fonterra grants $43K to Indonesian for bone R&D

Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...

July 25, 2013 | Thursday | News
Mylan launches generic hypertension drug in US

Singapore: Global pharmaceutical firm, Mylan, has launched Telmisartan tablets-20 mg, 40 mg and 80 mg, the generic versi...

July 10, 2014 | Thursday | Regulatory
New tech promises revenue boost for drug makers

Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to impro...

June 12, 2013 | Wednesday | Influencers
Abbott to sell branded generics business to Mylan

Singapore: Global pharmaceutical firm Abbott is planning to sell its developed markets branded generics pharmaceuticals ...

July 15, 2014 | Tuesday | News
Another Ranbaxy plant faces US FDA ire

Singapore: The year 2014 is bringing back haunting memories of the way the year gone by had started for India's biggest ...

January 14, 2014 | Tuesday | News
Takeda diabetes drug gets China's import license

Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 di...

August 6, 2013 | Tuesday | News
Dr. Reddy's launches Aricept generic Donepezil

Singapore: Dr. Reddy's Laboratories has launched Donepezil Hydrochloride tablets, 23 mg, a therapeutic equivalent generi...

July 29, 2013 | Monday | News
Japan pharma to grow at 2% CAGR from 2013-20

Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan...

July 11, 2013 | Thursday | Analysis
ULURU inks pact with Japanese medical firm

Texas-headquartered ULURU Inc has expanded its distribution network by entering into a cooperation agreement with Saraya...

June 6, 2016 | Monday | News
Japan approves generic drug for osteoporosis

Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (gene...

December 28, 2012 | Friday | Regulatory
Teva launches generic of cancer drug Temodar in US

Singapore: Israel-based Teva Pharmaceutical and US-based Perrigo have launched generic version of cancer drug Temodar (t...

August 16, 2013 | Friday | News
Taiwan firm gets ANDA approval for generics of Pfizer's Procardia

Singapore: Taiwan's TWi Pharmaceuticals has recieved ANDA approval of the generic equivalent to Procardia XL (Nifedipine...

April 9, 2014 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls